Sign in

CIK 0001711754

  • Non-accelerated filer
  • Smaller reporting company

Inmune Bio, Inc.

Sign in to watch
Ticker
INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
475205835
Phone
+1 858-964-3720
Business address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4/A Open-market buy CFO, Treasurer & Secretary bought 18,028 shares at $8.32 ($149,993)
  4. 4/A Open-market buy President and CEO bought 18,028 shares at $8.32 ($149,993)
  5. 4/A Open-market buy Chief Scientific Officer bought 14,423 shares at $8.32 ($119,999)
  6. 4/A Open-market buy Director bought 29,603 shares at $8.32 ($246,297)
  7. 4 Grant or award President and CEO acquired 18,028 shares (grant or award)
  8. 4 Grant or award CFO, Treasurer & Secretary acquired 18,028 shares (grant or award)
  9. 4 Grant or award Chief Scientific Officer acquired 14,423 shares (grant or award)
  10. 4 Grant or award Director acquired 29,603 shares (grant or award)
  11. 4 Open-market buy Director bought 7,000 shares at $6.95 ($48,650)
  12. 4 Planned sale Director sold 10,000 shares at $11.01 ($110,085)
  13. 4 Open-market buy CFO, Treasurer & Secretary bought 2,500 shares at $6.43 ($16,063)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 8 · 142 filings